查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1472372

吸入胶囊市场：按类型、按应用划分：2023-2032 年全球机会分析与产业预测

Inhalation Capsules Market By Type (Gelatin Capsules, Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 320 Pages | 商品交期: 2-3个工作天内

价格

全球吸入胶囊市场预计到 2032 年将达到 14.649 亿美元，2023 年至 2032 年复合年增长率为 6.4%，而 2022 年为 8.224 亿美元。

吸入胶囊市场-IMG1

吸入胶囊由于能够将药物直接输送到肺部，因此可以快速且强化地治疗呼吸系统疾病。这种客製化的剂量策略可以提高治疗效果，同时最大限度地减少全身副作用。胶囊通常设计为与特殊吸入装置一起使用，例如干粉吸入器（DPI）或定量吸入器（MDI）。随着製药业不断寻求新的、更有效的药物治疗方法，吸入胶囊正在成为可行的选择。

预计推动市场成长的主要原因之一是透过吸入实现的药物输送的出色功效。呼吸系统提供了直接有效的循环途径，使药物活动能够立即开始。这对于治疗以严重恶化为特征、需要立即缓解的疾病尤其重要。肺部为药物吸收提供了巨大的表面积，薄的肺泡膜使治疗化学物质能够快速到达血液。因此，吸入胶囊比传统口服给药表现出更快、更直接的药理反应，使患者能够更快地缓解症状并获得更好的整体结果。快速起效提高了吸入胶囊的有效性。

监督药品（尤其是吸入胶囊）的法律规范是预计阻碍市场收益成长的主要因素之一。监管机构使用严格的标准和流程来确保药品的安全性、有效性和高品质。製造商必须遵守良好生产规范 (GMP)，并且必须完全控制製造流程的每个步骤。遵守这些法规需要在技术、设备和人员培训方面进行大量投资，这增加了整个製造过程的复杂性。吸入胶囊的复杂设计和内容物增加了其复杂性。这些胶囊通常包含聚合物等特殊材料，并且必须满足严格的稳定性、相容性和生物相容性标准。

吸入胶囊为製药公司重新配製现有药物或引入可透过呼吸途径成功给药的新化学物质提供了独特的机会。吸入胶囊具有起效更快、全身副作用更少和患者依从性更好等优点，有可能振兴药物开发平臺。製药业可以利用这些前景，投资研发生产用于各种治疗领域的吸入製剂，包括呼吸系统疾病、全身性疾病，甚至免疫接种。所有这些因素预计将在预测期内为吸入胶囊市场创造一些成长机会。

本报告介绍的主要企业包括 Capsugel、Qualicaps、ACG Worldwide、Cipla、诺华、阿斯特捷利康 plc、Chiesi Farmaceutici SpA、Elpen SA、Vectura Group Plc 和 Boehringer Ingelheim GmbH。市场参与企业继续透过产品系列多元化和併购等策略，努力在竞争激烈的市场中获得优势地位。

相关人员的主要利益

  • 该报告提供了 2022 年至 2032 年吸入胶囊市场分析的细分市场、当前趋势、估计/趋势和动态的定量分析，并确定了吸入胶囊市场的强大机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出利润驱动的商业决策并加强供应商-买家网路的效力。
  • 吸入胶囊市场区隔的详细分析将有助于确定市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前位置的清晰了解。
  • 该报告包括对区域和全球吸入胶囊市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 製造能力
  • 产品生命週期
  • 打入市场策略
  • 按产品/细分市场细分
  • 新产品开发/主要企业产品矩阵
  • 监管指引
  • 针对客户兴趣的其他公司简介
  • 十字交叉细分市场分析—市场规模与预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）
  • 全球/区域/国家层级参与者的市场占有率分析
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 平均售价
  • 市场占有率分析
  • 品牌占有率分析
  • 贸易资料分析
  • 产品消费
  • 价值链分析
  • 关键监管分析
  • 专利情况
  • 监管指引
  • 赎回场景

第四章吸入胶囊市场：依类型

  • 概述
  • 明胶胶囊
  • 羟丙甲纤维素胶囊

第五章吸入胶囊市场：依应用分类

  • 概述
  • 气喘治疗
  • 慢性阻塞性肺病管理
  • 其他的

第六章吸入胶囊市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 伊尔泰
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他的

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第八章 公司简介

  • Capsugel
  • Qualicaps
  • ACG Worldwide
  • Cipla
  • Novartis
  • AstraZeneca Plc
  • CHIESI Farmaceutici SpA
  • Elpen SA
  • Vectura Group plc.
  • Boehringer Ingelheim GmbH
Product Code: A296225

The global inhalation capsule market is anticipated to reach $1,464.9 million by 2032, growing from $822.4 million in 2022 at a CAGR of 6.4 % from 2023 to 2032.

Inhalation Capsules Market - IMG1

Inhalation capsules' capacity to deliver medications directly to the lungs allows for quick and concentrated treatment of respiratory illnesses. This customized administration strategy minimizes systemic side effects while boosting therapeutic efficacy. Typically, capsules are designed to be used with specialized inhalation devices such as dry powder inhalers (DPIs) or metered-dose inhalers (MDIs). As the pharmaceutical industry continues to look for new and more effective ways to provide medication, inhalation capsules are emerging as a viable option.

One of the key reasons projected to drive the market growth is the exceptional efficacy of medicine delivery achieved by inhalation. The respiratory system offers a direct and efficient route to the circulation, allowing medication activity to begin immediately. This is particularly crucial for treating diseases characterized by severe aggravations, as quick relief is required. The lungs provide a huge surface area for drug absorption, and the thin alveolar membranes allow therapeutic chemicals to reach the bloodstream rapidly. As a result, inhalation capsules give a more rapid and direct pharmacological response than traditional oral delivery, allowing patients to experience quicker relief and better overall outcomes. The rapid onset of action increases the efficacy of inhalation capsules.

Stringent regulatory framework that oversees pharmaceutical products, particularly inhalation capsules is one of the major factors anticipated to hamper the market revenue growth. Regulatory authorities use strict criteria and processes to ensure that pharmaceuticals are safe, effective, and of high quality. Manufacturers need to stick to Good Manufacturing Practices (GMP), which requires maintaining complete control over every stage of the production process. Compliance with these regulations necessitates substantial investment in technology, equipment, and personnel training, which adds to the overall complexity of the production process. The intricate design and content of inhalation capsules contribute to their complexity. These capsules usually include specialized materials, such as polymers, that must meet stringent stability, compatibility, and biocompatibility criteria.

Inhalation capsules provide pharmaceutical firms a unique chance to reformulate current medications or introduce novel chemicals that can be successfully given via the respiratory route. Inhalation capsule has the potential to revitalize drug development pipelines by providing benefits such as a faster start of action, less systemic adverse effects, and better patient compliance. The pharmaceutical sector may capitalize on these prospects by investing in R&D to produce inhalable formulations for a variety of therapeutic areas, including respiratory disorders, systemic ailments, and even vaccinations. All these factors are anticipated to create several growth opportunities in the inhalation capsules market during the forecast period.

The key players profiled in this report include Capsugel, Qualicaps, ACG Worldwide, Cipla, Novartis, AstraZeneca plc, Chiesi Farmaceutici S.p.A., Elpen S.A., Vectura Group Plc, and Boehringer Ingelheim GmbH. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as diversification of product portfolios & mergers and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inhalation capsules market analysis from 2022 to 2032 to identify the prevailing inhalation capsules market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the inhalation capsules market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global inhalation capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Manufacturing Capacity
  • Product Life Cycles
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Type

  • Gelatin Capsules
  • Hypromellose Capsules

By Application

  • Asthma Treatment
  • COPD Management
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Iltay
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Capsugel
    • Qualicaps
    • ACG Worldwide
    • Cipla
    • Novartis
    • AstraZeneca Plc
    • CHIESI Farmaceutici S.p.A.
    • Elpen S.A.
    • Vectura Group plc.
    • Boehringer Ingelheim GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Regulation Analysis
  • 3.12. Patent Landscape
  • 3.13. Regulatory Guidelines
  • 3.14. Reimbursement Scenario

CHAPTER 4: INHALATION CAPSULES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Gelatin Capsules
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Hypromellose Capsules
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: INHALATION CAPSULES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Asthma Treatment
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. COPD Management
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: INHALATION CAPSULES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. UK
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. France
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Iltay
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. United Arab Emirates
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by Application
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Market size and forecast, by Type
      • 6.5.4.5.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Capsugel
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
  • 8.2. Qualicaps
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
  • 8.3. ACG Worldwide
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
  • 8.4. Cipla
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
  • 8.5. Novartis
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
  • 8.6. AstraZeneca Plc
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
  • 8.7. CHIESI Farmaceutici S.p.A.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
  • 8.8. Elpen S.A.
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
  • 8.9. Vectura Group plc.
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
  • 8.10. Boehringer Ingelheim GmbH
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 05. INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. INHALATION CAPSULES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. INHALATION CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. NORTH AMERICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 12. U.S. INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. U.S. INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. CANADA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. CANADA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. GERMANY INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. UK INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. UK INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. ILTAY INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. ILTAY INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. REST OF EUROPE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. CHINA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. CHINA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. JAPAN INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. JAPAN INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. INDIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. INDIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. SOUTH KOREA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. SOUTH KOREA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. AUSTRALIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. AUSTRALIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. LAMEA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. LAMEA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. LAMEA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 51. BRAZIL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. BRAZIL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. SAUDI ARABIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. SAUDI ARABIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. SOUTH AFRICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SOUTH AFRICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. REST OF LAMEA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF LAMEA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. CAPSUGEL: KEY EXECUTIVES
  • TABLE 62. CAPSUGEL: COMPANY SNAPSHOT
  • TABLE 63. QUALICAPS: KEY EXECUTIVES
  • TABLE 64. QUALICAPS: COMPANY SNAPSHOT
  • TABLE 65. ACG WORLDWIDE: KEY EXECUTIVES
  • TABLE 66. ACG WORLDWIDE: COMPANY SNAPSHOT
  • TABLE 67. CIPLA: KEY EXECUTIVES
  • TABLE 68. CIPLA: COMPANY SNAPSHOT
  • TABLE 69. NOVARTIS: KEY EXECUTIVES
  • TABLE 70. NOVARTIS: COMPANY SNAPSHOT
  • TABLE 71. ASTRAZENECA PLC: KEY EXECUTIVES
  • TABLE 72. ASTRAZENECA PLC: COMPANY SNAPSHOT
  • TABLE 73. CHIESI FARMACEUTICI S.P.A.: KEY EXECUTIVES
  • TABLE 74. CHIESI FARMACEUTICI S.P.A.: COMPANY SNAPSHOT
  • TABLE 75. ELPEN S.A.: KEY EXECUTIVES
  • TABLE 76. ELPEN S.A.: COMPANY SNAPSHOT
  • TABLE 77. VECTURA GROUP PLC.: KEY EXECUTIVES
  • TABLE 78. VECTURA GROUP PLC.: COMPANY SNAPSHOT
  • TABLE 79. BOEHRINGER INGELHEIM GMBH: KEY EXECUTIVES
  • TABLE 80. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. INHALATION CAPSULES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF INHALATION CAPSULES MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN INHALATION CAPSULES MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN INHALATION CAPSULES MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL INHALATION CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IMPACT OF KEY REGULATION: INHALATION CAPSULES MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. INHALATION CAPSULES MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. INHALATION CAPSULES MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. INHALATION CAPSULES MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 22. U.S. INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. CANADA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. MEXICO INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. GERMANY INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. UK INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. FRANCE INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. SPAIN INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. ILTAY INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. REST OF EUROPE INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. CHINA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. JAPAN INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. INDIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SOUTH KOREA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. AUSTRALIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. BRAZIL INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SAUDI ARABIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SOUTH AFRICA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF LAMEA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: INHALATION CAPSULES MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2022